Cadrenal Therapeutics, Inc.

New Filing
CIK: 0001937993·Biotechnology·DELAWARE·Filed: Dec 8, 2022
Total Offering

$1,000,000

Amount Sold

$250,000

Investors

2

First Sale

Nov 30, 2022

Offering Details

Type
Debt, Security to be Acquired, Other: Units consisting of 10% promissory note and warrant to purchase common stock
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2022
Non-Accredited Investors
No

Related Persons

NameRole
Quang Pham
Related Person
Matthew Szot
Related Person
Douglas Losordo
Related Person

Company

Cadrenal Therapeutics, Inc.

822 A1A NORTH, SUITE 306

PONTE VEDRA, FL, 32082

(904) 300-0701

SEC Filing

0001213900-22-078460

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free